Health Care & Life Sciences » Pharmaceuticals | GlaxoSmithKline PLC

GlaxoSmithKline PLC | Mutual Funds

Mutual Funds that own GlaxoSmithKline PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
102,671,800
2.06%
12,782,094
0.25%
12/31/2017
Dodge & Cox International Stock Fund
70,270,800
1.42%
-1,500,000
2.4%
06/30/2018
Vanguard Total International Stock Index Fund
69,365,481
1.4%
1,081,849
0.4%
07/31/2018
American Funds Income Fund of America
52,391,000
1.06%
2,000,000
1.07%
06/30/2018
Caisse de Dépôt & Placement du Québec
41,092,082
0.83%
6,803,780
0.31%
12/31/2017
American Funds Capital Income Builder
32,863,000
0.66%
5,714,000
0.7%
06/30/2018
Vanguard Developed Markets Index Fund
27,482,562
0.55%
-22,312
0.51%
07/31/2018
iShares MSCI EAFE ETF
24,345,648
0.49%
0
0.7%
09/06/2018
BlackRock CIF - UK Equity Tracker Fund
21,150,896
0.43%
0
3.1%
01/31/2018
Franklin Mutual Global Discovery Fund
19,892,359
0.4%
6,114,517
2.02%
03/31/2018

About GlaxoSmithKline

View Profile
Address
980 Great West Road
Brentford Greater London TW8 9GS
United Kingdom
Employees -
Website http://gsk.com
Updated 07/08/2019
GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases.